Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Nov 14.
Published in final edited form as: Cancer Cell Microenviron. 2017 Jul 3;4(2):e1567.

The regulation of snail: on the ubiquitin edge

Qian Yu 1,3, Binhua P Zhou 2,3, Yadi Wu 1,3
PMCID: PMC5685547  NIHMSID: NIHMS890246  PMID: 29147673

Abstract

Metastasis accounts for a majority of cancer death. One key feature during metastasis is epithelial-mesenchymal transition (EMT), which is regulated by transcription factors such as Snail and Twist. In non-malignant cells, Snail has a short half-life and is degraded via ubiquitination, but its stability is increased in cancer cell. However, the mechanism by which Snail escapes ubiquitination and degradation remains unknown. Recently, we found that Dub3 is a deubiquinase of Snail. Most importantly, we determined that Dub3 responded to extracellular signals such as IL-6, and that the resultant signaling prevented Snail degradation, and promoted cancer growth, invasion, and migration. In this highlight, we present a concise picture of how the transcription factor Snail is regulated by ubiquitination in cancer cells, the role of Dub3 in this process, and its potential use as a treatment target.

Keywords: metastasis, EMT, Snail, Dub3, ubiquitination

The ubiquitination of Snail

Metastasis accounts for 90% of cancer deaths [1]. In order to establish new growth at a distant location, cancer cells undergo invasion, intravasation, extravasation, and metastatic colonization [24]. During this process, EMT is necessary for cancer cells to lose their original intercellular adhesion and initially adopt an increased motility [5, 6]. Similar to the establishment of gestation layers by embryological cells, cancer cells undergoing EMT re-overexpress transcription factors such as Slug, Twist, and Snail, which repress proteins such as cadherin, claudin, integrin, cytokine, as well as others [5, 7]. Among these molecular triggers, Snail, a zinc finger protein family member, has been widely acknowledged for its role in EMT [5, 810]. Clinically, Snail expression is associated with resistance to chemotherapy, decreased survival, high recurrence rates and a poor prognosis [1113]. In accordance with its profound role in development, Snail has a short half-life and is tightly regulated by extracellular signaling, induced phosphorylation and degradation through ubiquitination [14].

The ubiquitination proteasome pathway is one approach utilized by cells to degrade targeted protein in eukaryotic cell [5]. During this process, ubiquitin, a 76 aminoacid peptide, initially forms a thio-ester bond with the ubiquitin activating enzyme (E1) and then is transferred to a ubiquitin conjugating enzyme (E2). Subsequently, a ubiquitin ligating enzyme (E3) catalyzes the formation of a covalent bond between ubiquitin and a lysine residue on the target protein, which then becomes susceptible to proteasomal degradation [15]. Snail’s ubiquitination and degradation are controlled by several F-box ligases, including β-TRCP1/Fbxw1, Fbxl14, Fbxl5, Fbxo11, and Fbxo45 [1622] (Figure 1). β-TRCP1/Fbxw1 is one of the best-characterized Snail E3 ligase. To initiate the even, phosphorylation of Snail by GSK3β on residues S104 and S107 promotes Snail localization to the cytoplasm; additional phosphorylation events by GSK3β on the S96 and S100 residues generate the β-TRCP1 phosphodegron [17]. Fbxl14, a cytoplasmic F-box protein, shares the same lysine residues as β-TRCP1 in the Snail N-terminal domain: K98, K137 and K146 and through these associations ligates ubiquitin to Snail [21]. Through global shRNA screening of F-box proteins, Fbxl5 was identified as targeting Snail. Fbxl5 is localized predominantly in the nucleus. Interestingly, Fbxl5 interacts with the Snail C-terminus, the region involved in binding to the E-box sequence while it polyubiquitinates Snail on its N-terminal residues K85 and K146 as well as on its C-terminal residue K234 [18]. In addition, Fbxl5-induced Snail down-regulation is impaired by post-translational modifications that prevent nuclear export, such as Lats2 phosphorylation [23]. Fbxo11 is another ubiquitin ligase that targets the SNAG domain of Snail [19,24]. Whether Snail degradation by Fbxo11 is dependent on S11 phosphorylation by the PKD1 is controversial and needs confirmation. The role of PKD1–induced Snail phosphorylation is complex since PKD1 can either inhibit or enhance Snail transcriptional repression [25, 26]. Fbxo45 is an atypical F-box protein induced by estrogen [27]. Fbxo45 interacts with Snail through its F-box domain. Surprisingly, several of these E3 ligases interacts as well with Slug, Zeb1 and Twist such as β-TRCP1, Fbxl14 and Fbxo45 while only Fbxl5 specifically interacts with Snail. Previously, we found that the expression of Snail can be stabilized by NF-κB at both transcriptional and post-translational levels, to downregulate the expression of E-cadherin and facilitate EMT [22, 28].

Figure 1. The ubiquitination regulation of Snail.

Figure 1

Snail is degraded by several E3 ligase including β-TRCP1, Fbxl14, Fbxl5, FBXO11 and Fbxo45. By contrast, Dub3 deubiquitinates Snail and prevents snail degradation through two axis: (1) the IL-6/Dub3/Snail axis: the extracellular IL-6 signal leads to increased Dub3 activity; (2) CDK4/6/Dub3/Snail axis: CDK4/6 phosphorylates Dub3 at Ser41. Dub3 is responsible for EMT, cancer stem cell like traits, and invasiveness through Snail stabilization.

The deubiquitination of Snail

One way to counteract this E3 ligase-mediated protein degradation is through deubiquitinase, which removes the ubiquitin moieties from target proteins and increases their stability [29]. Deubiquitinase enzymes (DUBs) are classified as UCH, USP, JAMM, OTU, and Ataxin-3/Josephin group. Growing evidence shows that DUBs are essential for the regulation of many cellular functions including transcription, DNA repair, apoptosis and cell cycle progression [30]. Dub3 belongs to the USP group. Whereas Dub1 and Dub2 were identified in mice, Dub3 is their human counterpart [31]. This family of growth-regulatory deubiquitinating enzymes are immediate-early genes and are induced rapidly and transiently in response to cytokine stimuli [32]. Within last few years, the role of Dub3 has emerged as an important deubiquitinase in DNA repair, cell proliferation, transcriptional factor regulation and tumor metastasis. For example, by deubiquitinating histones H2A and H2B, Dub3 impedes the recruitment of DNA repair factors such as 53BP1 and BRCA1 and cripple the DNA damage response that occurs with genotoxic stress [33]. By decreasing the turnover rate of cdc25A phosphatase, Dub3 facilitates the G1/S transition and promote cancer cell proliferation [34,35]. Dub3 also regulate YAP/TAZ activity by controlling the stability of the E3 ligase ITCH, the LATS kinases and the AMOT family proteins [36]. Using siRNA library screen targeting the 99 known or putative DUBs, we identified Dub3 is a deubiquitinase of Snail. Dub3 stabilizes Snail via deubiqutination, downregulating E-cadherin expression and promoting EMT [37, 38]. The interaction of Snail with Dub3 is mediated at the N-terminal region of Snail, which holds the SNAG domain and is the most common binding site for E3 [38]. Expression of Dub3 blocked Snail degradation mediated by the E3 ligases Fbxl14 and Fbxw1/β-TRCP1 [38]. Functionally, we found that the expression of Dub3 in breast cancer cell lines not only downregulates markers of luminal type of breast cancer, but also upregulates molecules associated with BLBC [38]. Knockdown of Dub3 inhibits migration, invasion and cancer stem cell (CSC)-like characteristics in cells by downregulating of Snail. By contrast, ectopic expression of Dub3 induces EMT through an upregulation of Snail. Most importantly, we found that depletion of Dub3 not only dampened spontaneous lung metastasis but also inhibited tumor recurrence. Clinically, Dub3 overexpression predicts a shortened relapse-free survival and higher probability of distant metastasis. These results strongly suggest that Dub3 can be a therapeutic target.

IL-6, a major cytokine present in the tumor microenvironment, can induce EMT and promote metastasis through the STAT3 signaling pathway in breast cancer, head and neck cancer and pancreatic cancer [39]. Increased IL-6 level predicts tumor recurrence, a poor response to chemotherapy, poor survival, and tumor metastasis [40]. IL-6 is also identified as a major cytokine secreted by BLBC cells and is essential for the CSC-like characteristic of BLBC [41]. Interestingly, Dub3 activity and expression, at both the mRNA and protein levels, can be induced by IL-6 through the JAK/STAT3 signaling pathway [31, 38, 39]. Consistent with this, we also found that IL-6 rapidly induces Dub3 expression, exerting a maximum effect at 2hr [38]. Dub3-knockdown not only reduced the endogenous level of Snail but also blocked IL-6-induced Snail stabilization and invasion. Thus, DUB3 could be a missing bridge between the extracellular signaling in the tumor environment and intracellular changes in genomic expression, and explains how tumor-promoting inflammation can facilitate cancer metastasis. These data delineate a key role by Dub3 in connecting extracellular inflammatory signals to invasion, CSC-like traits, and drug resistance.

Considering the crucial role of Dub3 in triggering EMT and metastasis, we screened several Dub3 inhibitors and found that WP1130 could bind to the catalytic site of Dub3. In vitro, WP1130 inhibited cell migration, invasion, and mammosphere formation, whereas in vivo, tumor growth decreased significantly after treatment [38]. By blocking the interaction of Dub3 and Snail, WP1130 prevents the deubiquitination of Snail, thereby blocking cancer invasion, migration, and the establishment of CSC-like properties. Concurrently, palbociclib, a specific inhibitor of CDK4/6, was reported to decrease Snail stability in a Dub3-dependent manner [37]. CDK4/6 phosphorylates Dub3 at Ser41, a crucial site for Dub3 activity in the regulation of Snail’s stability [37]. By acting on the CDK4/6-Dub3-Snail axis, palbociclib reduced cancer cell migration and metastasis in vitro and in vivo. In both cases, the ultimate target was the Dub3-Snail interaction, suggesting critical role of Dub3-Snail axis in cancer progression and metastasis (Figure 1).

Conclusion

Snail has been well acknowledged for its importance in mediating EMT and tumor metastasis. Its stability is crucial for cancer progression and metastasis. We have identified Dub3 as the key regulator of Snail and the missing link between extracellular signaling from sources such as IL-6 in tumor environment, and the gene expression changes in cells that promote cancer. In addition, we exploited Dub3’s value as a therapeutic target. WP1130 reduces cancer migration and metastasis by inhibiting Dub3’s catalytic activity and thereby restores the ubiquitination-mediated degradation of Snail. Based on Dub3’s dual role in regulating tumor growth and metastasis, future clinical and pharmaceutical investigations could be directed towards this specific interaction of Dub3-Snail. Last but not least, while our study indicated that Dub3 could counteract the function of β-TRCP1 and Fbxl14 in regulating the degradation of Snail, both β-TRCP1 and Fbxl14 could also influence the stability of Slug, ZEB1 and Twist. Future research could explore Dub3’s role in regulating these transcription factors [21,42,43].

Acknowledgments

We thank Dr. Cathy Anthony for the critical editing of this manuscript. Our research was supported by the Shared Resources of the University of Kentucky Markey Cancer Center (P30CA177558). Our research was also supported by grants from NIH (CA125454 and CA188118), DoD (BC140733P1), Mary Kay Ash Foundation (to B.P. Zhou), and American Cancer Society Research Scholar Award (RSG13187) and NIH (P20GM121327) (to Y Wu).

Abbreviations

PKD1

Protein Kinase D 1

GSK3β

Glycogen Synthase Kinase3

FBXW1

F-box/WD repeat-containing protein 1

Fbxl

F-box and leucine-rich repeat protein

Fbxo

F-boxes other

UCH

ubiquitin C-terminal hydrolase

USP

ubiquitin-specific processing proteases

JAMM

Jab1/Pad1/MPN domain containing metallo-enzymes

OUT

Otu domain ubiquitin-aldehyde binding proteins

Ataxin-3/Josephin

Ataxin-3/Josephin domain containing proteins

53BP1

p53 binding protein 1

BRCA1

Breast Cancer gene 1

cdc25a

Cell Division Cycle 25 Homolog A

YAP

Yes Associated Protein 1

TAZ

Tafazzin

ITCH

Itchy E3 Ubiquitin Protein Ligase

LATS

Large Tumor Suppressor Kinase

AMOT

Angiomotin

IL-6

Interleukin-6

JAK

Janus Kinase

STAT3

Signal Transducer And Activator Of Transcription 3

CDK

Cyclin Dependent Kinase

BLBC

basal-like breast cancer

Footnotes

Conflicting interests

The authors have declared that no conflict of interests exist.

Author contributions

Q.Y., B.Z., and Y.W. wrote the manuscript.

References

  • 1.Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer. 2006;6:449–458. doi: 10.1038/nrc1886. [DOI] [PubMed] [Google Scholar]
  • 2.Zeeshan R, Mutahir Z. Cancer metastasis - tricks of the trade. Bosn J Basic Med Sci. 2017 doi: 10.17305/bjbms.2017.1908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. doi: 10.1016/j.cell.2011.02.013. [DOI] [PubMed] [Google Scholar]
  • 4.McAllister SS, Weinberg RA. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol. 2014;16:717–727. doi: 10.1038/ncb3015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wu Y, Zhou BP. Snail: More than EMT. Cell Adh Migr. 2010;4:199–203. doi: 10.4161/cam.4.2.10943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7:131–142. doi: 10.1038/nrm1835. [DOI] [PubMed] [Google Scholar]
  • 7.Martin TA, Goyal A, Watkins G, Jiang WG. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol. 2005;12:488–496. doi: 10.1245/ASO.2005.04.010. [DOI] [PubMed] [Google Scholar]
  • 8.Peinado H, Ballestar E, Esteller M, Cano A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol. 2004;24:306–319. doi: 10.1128/MCB.24.1.306-319.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol. 2002;3:155–166. doi: 10.1038/nrm757. [DOI] [PubMed] [Google Scholar]
  • 10.Wu SY, McClay DR. The Snail repressor is required for PMC ingression in the sea urchin embryo. Development. 2007;134:1061–1070. doi: 10.1242/dev.02805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Nomura S, Suzuki Y, Takahashi R, Terasaki M, Kimata R, Hamasaki T, et al. Snail expression and outcome in T1 high-grade and T2 bladder cancer: a retrospective immunohistochemical analysis. BMC Urol. 2013;13:73. doi: 10.1186/1471-2490-13-73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ayala G, Thompson T, Yang G, Frolov A, Li R, Scardino P, et al. High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence. Clin Cancer Res. 2004;10:6572–6578. doi: 10.1158/1078-0432.CCR-04-0477. [DOI] [PubMed] [Google Scholar]
  • 13.Shi Y, Wu H, Zhang M, Ding L, Meng F, Fan X. Expression of the epithelial-mesenchymal transition-related proteins and their clinical significance in lung adenocarcinoma. Diagn Pathol. 2013;8:89. doi: 10.1186/1746-1596-8-89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Muqbil I, Wu J, Aboukameel A, Mohammad RM, Azmi AS. Snail nuclear transport: the gateways regulating epithelial-to-mesenchymal transition? Semin Cancer Biol. 2014;27:39–45. doi: 10.1016/j.semcancer.2014.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Skieterska K, Rondou P, Van Craenenbroeck K. Regulation of G Protein-Coupled Receptors by Ubiquitination. Int J Mol Sci. 2017:18. doi: 10.3390/ijms18050923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Diaz VM, de Herreros AG. F-box proteins: Keeping the epithelial-to-mesenchymal transition (EMT) in check. Semin Cancer Biol. 2016;36:71–79. doi: 10.1016/j.semcancer.2015.10.003. [DOI] [PubMed] [Google Scholar]
  • 17.Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol. 2004;6:931–940. doi: 10.1038/ncb1173. [DOI] [PubMed] [Google Scholar]
  • 18.Vinas-Castells R, Frias A, Robles-Lanuza E, Zhang K, Longmore GD, Garcia de Herreros A, et al. Nuclear ubiquitination by FBXL5 modulates Snail1 DNA binding and stability. Nucleic Acids Res. 2014;42:1079–1094. doi: 10.1093/nar/gkt935. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Jin Y, Shenoy AK, Doernberg S, Chen H, Luo H, Shen H, et al. FBXO11 promotes ubiquitination of the Snail family of transcription factors in cancer progression and epidermal development. Cancer letters. 2015;362:70–82. doi: 10.1016/j.canlet.2015.03.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Xu M, Zhu C, Zhao X, Chen C, Zhang H, Yuan H, et al. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors. Oncotarget. 2015;6:979–994. doi: 10.18632/oncotarget.2825. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Vinas-Castells R, Beltran M, Valls G, Gomez I, Garcia JM, Montserrat-Sentis B, et al. The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation. The Journal of biological chemistry. 2010;285:3794–3805. doi: 10.1074/jbc.M109.065995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Victor DW, 3rd, Quigley EM. The Microbiome and the Liver: The Basics. Semin Liver Dis. 2016;36:299–305. doi: 10.1055/s-0036-1593879. [DOI] [PubMed] [Google Scholar]
  • 23.Zhang K, Rodriguez-Aznar E, Yabuta N, Owen RJ, Mingot JM, Nojima H, et al. Lats2 kinase potentiates Snail1 activity by promoting nuclear retention upon phosphorylation. EMBO J. 2012;31:29–43. doi: 10.1038/emboj.2011.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Zheng H, Shen M, Zha YL, Li W, Wei Y, Blanco MA, et al. PKD1 phosphorylation-dependent degradation of SNAIL by SCF-FBXO11 regulates epithelial-mesenchymal transition and metastasis. Cancer cell. 2014;26:358–373. doi: 10.1016/j.ccr.2014.07.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Bastea LI, Doppler H, Balogun B, Storz P. Protein kinase D1 maintains the epithelial phenotype by inducing a DNA-bound, inactive SNAI1 transcriptional repressor complex. PloS one. 2012;7:e30459. doi: 10.1371/journal.pone.0030459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Du C, Zhang C, Hassan S, Biswas MH, Balaji KC. Protein kinase D1 suppresses epithelial-to-mesenchymal transition through phosphorylation of snail. Cancer research. 2010;70:7810–7819. doi: 10.1158/0008-5472.CAN-09-4481. [DOI] [PubMed] [Google Scholar]
  • 27.Yoshida K. Characterization of estrogen-induced F-box protein FBXO45. Oncol Rep. 2005;14:531–535. [PubMed] [Google Scholar]
  • 28.Cichon MA, Radisky DC. ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-kB-dependent activation of Snail. Oncotarget. 2014;5:2827–2838. doi: 10.18632/oncotarget.1940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, et al. A genomic and functional inventory of deubiquitinating enzymes. Cell. 2005;123:773–786. doi: 10.1016/j.cell.2005.11.007. [DOI] [PubMed] [Google Scholar]
  • 30.Reyes-Turcu FE, Ventii KH, Wilkinson KD. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annual review of biochemistry. 2009;78:363–397. doi: 10.1146/annurev.biochem.78.082307.091526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Burrows JF, McGrattan MJ, Rascle A, Humbert M, Baek KH, Johnston JA. DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. J Biol Chem. 2004;279:13993–14000. doi: 10.1074/jbc.M311291200. [DOI] [PubMed] [Google Scholar]
  • 32.Zhu Y, Lambert K, Corless C, Copeland NG, Gilbert DJ, Jenkins NA, et al. DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. The Journal of biological chemistry. 1997;272:51–57. doi: 10.1074/jbc.272.1.51. [DOI] [PubMed] [Google Scholar]
  • 33.Delgado-Diaz MR, Martin Y, Berg A, Freire R, Smits VA. Dub3 controls DNA damage signalling by direct deubiquitination of H2AX. Molecular oncology. 2014;8:884–893. doi: 10.1016/j.molonc.2014.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Pereg Y, Liu BY, O’Rourke KM, Sagolla M, Dey A, Komuves L, et al. Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. Nat Cell Biol. 2010;12:400–406. doi: 10.1038/ncb2041. [DOI] [PubMed] [Google Scholar]
  • 35.Hayes SD, Harper JW. Cdc25A and Dub3 in a high-stakes balancing act. Nat Cell Biol. 2010;12:311–313. doi: 10.1038/ncb2043. [DOI] [PubMed] [Google Scholar]
  • 36.Nguyen HT, Kugler JM, Cohen SM. DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins. PloS one. 2017;12:e0169587. doi: 10.1371/journal.pone.0169587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Liu T, Yu J, Deng M, Yin Y, Zhang H, Luo K, et al. CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1. Nat Commun. 2017;8:13923. doi: 10.1038/ncomms13923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Wu Y, Wang Y, Lin Y, Liu Y, Wang Y, Jia J, et al. Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation. Nat Commun. 2017;8:14228. doi: 10.1038/ncomms14228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N, et al. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene. 2009;28:2940–2947. doi: 10.1038/onc.2009.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Berishaj M, Gao SP, Ahmed S, Leslie K, Al-Ahmadie H, Gerald WL, et al. Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer. Breast Cancer Res. 2007;9:R32. doi: 10.1186/bcr1680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Marotta LL, Almendro V, Marusyk A, Shipitsin M, Schemme J, Walker SR, et al. The JAK2/STAT3 signaling pathway is required for growth of CD44(+)CD24(-) stem cell-like breast cancer cells in human tumors. J Clin Invest. 2011;121:2723–2735. doi: 10.1172/JCI44745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Frescas D, Pagano M. Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer. 2008;8:438–449. doi: 10.1038/nrc2396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Zhong J, Ogura K, Wang Z, Inuzuka H. Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasis. Discov Med. 2013;15:7–15. [PMC free article] [PubMed] [Google Scholar]

RESOURCES